Products and technical work
Observed October 20, 2026: Its INSIGHT portfolio addresses radiology and screening, while SCOPE covers pathology and biomarker-oriented oncology applications. Research question (analysis): How are dataset shift, imaging-system differences and task-specific validation handled across product families?
Company-published product scope, not independent validation of clinical efficacy, regulatory authorization, security, customer outcomes or employer quality. The research question is analysis, not an advertised job requirement.
Read the source